Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

M-16049: hypoglycemic agent and aldose reductase inhibitor

June 12, 1997

Otsuka AGE inhibitor prevents progression of diabetic nephropathy in animal model

June 12, 1997

Novel site of action for chimeric insulin-releasing peptide

June 12, 1997

BRL-48482 has potential for reducing cardiovascular risk in NIDDM

June 12, 1997

Phase III results for AY-4166

June 12, 1997

Pioglitazone improves insulin resistance in NIDDM

June 12, 1997

New preclinical studies on JTT-501

June 12, 1997

Clinical results in NIDDM reported for troglitazone

June 12, 1997

Efficacy of pioglitazone demonstrated in NIDDM patients

June 11, 1997

Midodrine efficacy in diabetic patients with orthostatic hypotension

June 11, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...